Theriva Biologics, Inc.

US$0.17As of Sun 8 Nov 2026, 12:00 UTC
AMEX:TOVXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (67.32%)
Div yield —
ROE (101.87%)
Biotechnology
Beta (5Y) 1.26
PE TTM —
TSR TTM (46.70%)
Mkt cap US$7.641M
ROIC (51.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.176
5.64%
(27.99%)
Hold 4|8|7|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
16.19%
17.29%
5.27%
7.66%
Revenue$M
0.446
0.472
0.468
0.463
21.34%
22.55%
15.27%
8.60%
Peers (US$7.641M)
Cap (US$)
PE
7.975M
—
7.291M
—
Capital
TTM
5Y
10Y
Leveragex
0.449
0.214
0.200
EBIT/Intx
7.778
0.227
0.261
Own earn%
(0.97)
261.00
202.61
Sh yield%
34.42
28.37
25.87
Owners
Insiders/Inst%
12.23
73.04
Short interest%
0.51
SBC / revenue%
0.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
34–38
$1 testx
—
Incr. ROIC%
1